Tech Company Financing Transactions
Idun Pharmaceuticals Funding Round
Idun Pharmaceuticals closed a $27 million Series A investment round on 6/14/2004. Backers included MPM Capital, Aberdare Ventures and Pacific Venture Partners.
Transaction Overview
Company Name
Announced On
6/14/2004
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series A
Investors
MPM Capital (Lead Investor) (Luke Evnin)
Sutter Hill Ventures (Jeffrey Bird)
Proceeds Purpose
Idun will use the proceeds to advance its clinical development programs in liver disease, bring new programs to the clinic and to fund general business operations.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12463 Rancho Bernardo Rd. 554
San Diego, CA 92128
USA
San Diego, CA 92128
USA
Phone
Website
Email Address
Not Recorded
Overview
Idun Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the areas of liver disease, inflammation, and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Mento
Browse more venture capital transactions:
Prev: 6/14/2004: Clarus Systems venture capital transaction
Next: 6/14/2004: Finjan Software venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs